Causal relationship between immune cells and atrial fibrillation: A Mendelian randomization study

Area of Science:

• Immunology
• Cardiology
• Genetics

Background:

• Atrial fibrillation (AF) is a common arrhythmia with a suspected link to immune system activity.
• The precise causal relationship between immune responses and AF development remains unclear, with uncertainty regarding whether immune changes are primary or secondary.

Purpose of the Study:

• To investigate the causal effect of immune cell characteristics on the development of atrial fibrillation.
• To differentiate between primary immune system effects and secondary consequences in AF pathogenesis.
• To identify specific immune factors that may serve as risk or protective elements in AF.

Main Methods:

• Employed forward and reverse Mendelian randomization (MR) analyses.
• Utilized genetic variants associated with immune cell exposures and AF as outcomes.
• Instrumental variables were selected to infer causality and address reverse causality concerns.

Main Results:

• Elevated CD25 on memory B cells was identified as a potential risk factor for AF (OR: 1.0233, P=0.0383).
• Higher CD4 regulatory T cell counts demonstrated a protective effect against AF development (OR: 0.9513, P=0.0086).
• Genetically inferred evidence supports a causal link between immune system components and AF.

Conclusions:

• Specific immune cell markers and counts have a genetically determined causal influence on atrial fibrillation.
• Findings suggest potential therapeutic targets within the immune system for managing AF.
• Further research into immune system modulation could lead to novel pharmaceutical interventions for AF.